Symbol: |
MED13L
|
Description: |
mediator complex subunit 13-like [Source:HGNC Symbol;Acc:22962]
|
Location: |
Chr12:116395711-116715143[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:367
Gene |
Compound |
Gen_sig |
Exp_pattern |
MED13L |
METHYLUNDECYLPIPERIDINE, TRANS |
0.013 |
Down |
MED13L |
NSC 168197 |
0.003 |
Down |
MED13L |
Bromocriptine methanesulfonate |
0.001 |
Down |
MED13L |
7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- |
0.029 |
Down |
MED13L |
NSC 175296 |
0.001 |
Down |
MED13L |
6-Aminotoyocamycin |
0.015 |
Down |
MED13L |
3-(2-PYRIDYL)-ACRYLOPHENONE |
0.021 |
Down |
MED13L |
TETRAAMMINECOPPER(2+) DITHIOCYANATE COMPOUND WITH QUINOLINE THIOCYANATE (1:3) |
0.005 |
Up |
MED13L |
1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- |
0.001 |
Down |
MED13L |
NSC 201902 |
0.001 |
Down |
MED13L |
1,8-Octanediamine, N,N'-di-9-acridinyl- |
0.042 |
Down |
MED13L |
Chrysanthin |
0.03 |
Down |
MED13L |
Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester |
0.008 |
Down |
MED13L |
2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- |
0.001 |
Down |
MED13L |
1-Piperidineethanol, .alpha.-[p-(p-chlorostyryl)phenyl]- |
0.014 |
Up |
Expression pattern: Sensitivity / Resistance
Total:25 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:35
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|